WHO ICTRP trial
Adipose derived stem cells as local treatment of ulcerative colitis
EUCTR2022-002325-99-DK · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2022-002325-99-DK |
|---|---|
| Public title | Adipose derived stem cells as local treatment of ulcerative colitis |
| Scientific title | Adipose derived mesenchymal stem cells as local treatment of ulcerative colitis |
| Primary sponsor | Aarhus University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Denmark |
| Conditions | Ulcerative colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Pharmaceutical Form: Injection Pharmaceutical form of the placebo: Injection Route of administration of the placebo: Submucosal use |
| Registration date | Nov 15, 2022 |
| Target size | 16 |
| Secondary IDs | MSC01 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: